JP Morgan Chase’s Mustang Bio MBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1 | Hold |
2
| – | – | ﹤0.01% | 7478 |
|
|
2025
Q4 | $2 | Hold |
2
| – | – | ﹤0.01% | 7373 |
|
|
2025
Q3 | $3 | Hold |
2
| – | – | ﹤0.01% | 7341 |
|
|
2025
Q2 | $2 | Sell |
2
-66
| -97% | -$80 | ﹤0.01% | 7013 |
|
|
2025
Q1 | $86 | Buy |
68
+65
| +2,167% | +$248 | ﹤0.01% | 6897 |
|
|
2024
Q4 | $24 | Hold |
3
| – | – | ﹤0.01% | 7245 |
|
|
2024
Q3 | $31 | Hold |
3
| – | – | ﹤0.01% | 7192 |
|
|
2024
Q2 | $63 | Hold |
3
| – | – | ﹤0.01% | 6978 |
|
|
2024
Q1 | $154 | Hold |
3
| – | – | ﹤0.01% | 6847 |
|
|
2023
Q4 | $180 | Hold |
3
| – | – | ﹤0.01% | 7062 |
|
|
2023
Q3 | $273 | Hold |
3
| – | – | ﹤0.01% | 6804 |
|
|
2023
Q2 | $826 | Hold |
3
| – | – | ﹤0.01% | 6484 |
|
|
2023
Q1 | $1K | Hold |
3
| – | – | ﹤0.01% | 6531 |
|
|
2022
Q4 | $1K | Sell |
3
-29
| -91% | -$9.9K | ﹤0.01% | 6422 |
|
|
2022
Q3 | $12K | Sell |
32
-2,031
| -98% | -$941K | ﹤0.01% | 5929 |
|
|
2022
Q2 | $905K | Sell |
2,063
-810
| -28% | -$448K | ﹤0.01% | 4171 |
|
|
2022
Q1 | $2.17M | Sell |
2,873
-190
| -6% | -$156K | ﹤0.01% | 3683 |
|
|
2021
Q4 | $3.81M | Buy |
3,063
+4
| +0.1% | +$6.46K | ﹤0.01% | 3284 |
|
|
2021
Q3 | $6.17M | Buy |
3,059
+430
| +16% | +$924K | ﹤0.01% | 2863 |
|
|
2021
Q2 | $6.55M | Sell |
2,629
-768
| -23% | -$1.88M | ﹤0.01% | 2810 |
|
|
2021
Q1 | $8.46M | Buy |
3,397
+1,141
| +51% | +$3.39M | ﹤0.01% | 2518 |
|
|
2020
Q4 | $6.4M | Sell |
2,256
-111
| -5% | -$265K | ﹤0.01% | 2598 |
|
|
2020
Q3 | $5.61M | Sell |
2,367
-212
| -8% | -$523K | ﹤0.01% | 2475 |
|
|
2020
Q2 | $6.15M | Buy |
2,579
+2,567
| +21,392% | +$6M | ﹤0.01% | 2302 |
|
|
2020
Q1 | $24K | Hold |
12
| – | – | ﹤0.01% | 4906 |
|
|
2019
Q4 | $37K | Hold |
12
| – | – | ﹤0.01% | 5207 |
|
|
2019
Q3 | $30K | Buy |
12
+2
| +20% | +$5.47K | ﹤0.01% | 5321 |
|
|
2019
Q2 | $27K | Buy |
10
+5
| +100% | +$14.3K | ﹤0.01% | 5384 |
|
|
2019
Q1 | $13K | Sell |
5
-5
| -50% | -$14.2K | ﹤0.01% | 5495 |
|
|
2018
Q4 | $23K | Buy |
10
+5
| +100% | +$15.2K | ﹤0.01% | 5295 |
|
|
2018
Q3 | $22K | Hold |
5
| – | – | ﹤0.01% | 5405 |
|
|
2018
Q2 | $23K | Buy |
+5
| New | +$31.6K | ﹤0.01% | 5275 |
|
Other funds holding MBIO
KAS
VFT
VCM
CG
TRCT
JP Morgan Chase's MBIO Position: Q1 2026 in Review
JP Morgan Chase held its Mustang Bio (MBIO) position steady in Q1 2026 at 2 shares worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #7478.
JP Morgan Chase first reported a position in MBIO in Q2 2018 and has held it in 32 quarters since. The position peaked at $8.46M in Q1 2021. 22 funds tracked by Wall St. Rank hold MBIO as of Q1 2026.
- JP Morgan Chase held 2 shares of Mustang Bio worth $1 as of Q1 2026.
- JP Morgan Chase left its Mustang Bio share count unchanged in Q1 2026.
- Mustang Bio made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7478 holding.
- JP Morgan Chase first reported a position in Mustang Bio in Q2 2018 and has held it in 32 quarters since.
- JP Morgan Chase's Mustang Bio position peaked at $8.46M in Q1 2021.
- 22 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.